drugset / Trial / NCT01675310

Medical Nutrition Therapy Plus Transgestational Metformin For Preventing Gestational Diabetes In High Risk Mexican Women

NCT01675310 ↗

RandomizedParallel-groupOpen-labelPrevention

Summary

Gestational diabetes mellitus is one of the most frequent complications of pregnancy, that affect between 1 to 14% of population around the world. There is a few studies to prevent gestational diabetes mellitus in high risk women as Mexican population. Metformin has been used during pregnancy in women with gestational diabetes and women with polycystic ovary syndrome, with acceptable security for mother and fetus. Metformin decrease the insulin resistance and weight gain, we believe that metformin may be decrease the risk of gestational diabetes mellitus in high risk women.

Timeline

Start
2012-01
Primary completion
2014-12
Completion
2015-03

Outcome

Missed primary endpoint

paper group: p = 0.42 (RR: 1.57 [95% CI: 0.67-3.68]). PMID 35010938 ↗

paper There is no benefit in adding metformin to intensive MNT to prevent GDM among high-risk Mexican women. PMID 35010938 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 850 mg —